Medical technology company Advita Ortho announced on Friday that it has updated Chime, its clinical exchange application designed to help orthopaedic surgeons connect, collaborate and share clinical insight.
Available exclusively to Advita surgeons, Chime is a secure, peer-to-peer platform designed to turn everyday cases into shared learning. Powered by Active Intelligence, the expanded Chime app adds new AI-assisted capabilities, workflow-based notifications and broader accessibility to support more meaningful collaboration.
New features include: AI-assisted case posting to help surgeons create posts faster using AI dictation, with support for images, videos and PDFs; GPS Shoulder notifications to alert surgeons when shoulder reconstructions are ready for planning and navigation; an updated user interface with a simplified design for easier navigation and engagement; and web access providing the ability to view and participate from a desktop or mobile device.
QT Imaging Debuts QT Imaging-Olea Viewer for integrated multimodality breast imaging
CS Analytical appoints director of Scientific Affairs
MedPal AI launches integrated health OS platform to drive scalable digital healthcare
CenExel appoints Dr. Sy Pretorius as CEO
QT Imaging launches next-generation breast imaging reconstruction software
Tempus and Medtronic report positive ALERT trial results for AI-driven cardiac care
US FDA approves i-Lumen Scientific's i-SIGHT2 clinical study for dry AMD
Edwards Lifesciences reports positive two-year data for EVOQUE valve system
Clarity Pharmaceuticals signs copper-64 manufacturing agreement with Theragenics
Thermo Fisher Scientific and SHL Medical launch integrated US drug-device manufacturing
Philips launches integrated IntraSight Plus platform to enhance coronary intervention efficiency
Laronix and Greater Baltimore Medical Center launch Laronix MIRA Voice investigational study
BD receives CE Mark for Revello vascular covered stent
GAIA and Daiichi Sankyo Europe partner on digital therapeutic for cardiovascular care
Airiver Medical's Airiver Pulmonary DCB receives US FDA Breakthrough Device Designation